At present, the best hope for eliminating
Introduction
We can estimate the relative risk of infection during the acute and chronic stages of infection in two ways. We can estimate it indirectly if we have data on the viral load in the acute and chronic stages and data on the probability of a transmission event as a function of viral load. [1] [2] [3] [4] [5] [6] We can estimate it directly if we have a sero-incident cohort with a short follow up time and if we can measure the number of infection events in each stage. 8 Both methods require a sero-incident cohort and repeated measurements of the viral load. Cohort data are always difficult to obtain and cohorts of discordant couples will become increasingly biased with time as those that are most likely to infect their partners do so and are removed from the cohort. Nevertheless, these are the data that we have.
Indirect estimates
We first ask: how does viral load vary from initial infection through sero-conversion and the acute phase to the chronic phase and eventually to the final phase shortly before death? The most useful data in this regard, based on two sets of archived samples from HIV infected plasma donors, are from Fiebig et al.
7 Figure 1 shows the observed median values of viral load as a function of time since infection. 7 The fitted (green) line is In Equation 2, N scales overall transmission up or down, the first logistic function l in the curly brackets increases with time at a rate α 1 reaching half the maximum value at time δ 1 , the second decreases with time at a rate α 2 reaching half the maximum value at time δ 2. β is the asymptotic value to which the viral load converges during the chronic phase. In short, the viral load increases at a rate α 1 to a peak value from which it converges downwards at a rate α 2 to an asymptote at β. The median value of the log 10 (viral load) during the chronic phase is 4.09 ± 0.31 and at the peak of the acute phase is 5.45 ± 0.15. The acute phase lasts from day 8 to day 70 after sero-conversion so that the duration of the acute phase, D AP = 62 days, during which time the average value of the median viral load is 4.73 ± 0.02 for an average increase of 0.7 logs or a factor of 10 0.7 = 5.0 (3.2−7.9) over the value during the chronic stage of infection. There are three sets of data on the risk of infection per unit time as a function of viral load 1, 3, 6 ( Figure 2 ). The simplest model of the relationship between viral load and transmission assumes that the former increases linearly with the latter (but see also Appendix 1). However, the data suggest that transmission saturates at high viral load and we therefore assume a relationship of the following form:
where T is the probability of transmission per year. At low viral loads transmission increases linearly as T = αρV so that the probability of infection per virion per mm 3 is αρ, transmission saturates at α transmissions per year and we can define V*, the viral load time at which transmission saturates, as the intercept of the initial linear increase with the asymptotic value so that
The fits in Figure 2 give the values in Table 1 . Allowing for the small amount of over-dispersion in the estimates we see that for low viral loads the probability of infection is 2.42×10 −6 (1.14×10 −6 −5.13×10 −6 ) times the viral load per mm 3 and at high viral loads transmission saturates when the viral load is 4.37±0.29 logs.
We can now estimate the probability of transmission at the peak of the acute phase, when the log 10 (median viral load) is 5.45, and in the chronic phase, when the log 10 (median viral load), using each of the three data sets. The ratio of the pairs of estimates gives RR, the relative risk of infection, per unit time, in the acute and the chronic phase as RR = 2.1 (1.1−3.9). 
Direct estimates
The most widely cited direct estimates of the relative transmission in the acute and chronic stages of HIV-infection are based on the Uganda study of Wawer et al. 8 The most reliable data, in this regard, are those from the incidence cohort in which there were 10 transmission events among 23 couples who had 1221 coital acts in the first six months after seroconversion and 2 transmission events among the remaining 13 couples who had 1313 coital acts in months 6 to 15 after seroconversion. This gives a relative risk of transmission RR = 3.4 (0.7−17.6). Wawer et al. 8 give an unadjusted estimate of the RR of transmission, comparing the acute phase to the 'prevalent' cases, of 8.25 (3.37-20.22) but since the risk of transmission in 'prevalent' cases is close to half of the risk in incident cases 6 to 15 months after sero-conversion, their estimate of the RR, using those in the incidence cohort who were infected 6 to 15 months after sero-conversion, would be 4.1 (1.6−10.1). This is still significantly higher than the indirect estimate given above, especially since the Wawer et al. 8 estimate is averaged over six months while the estimate made here is averaged over two months. In order to favour the importance of the acute phase on the epidemic we will use the high estimate from Wawer et al. 8 Now, consider a cohort of newly infected people. Viral load varies considerably among people infected with HIV. From data on the distribution of viral load in a cross-sectional study from Orange Farm, South Africa 12 (Bertran Auvert, personal communication) log 10 (viral load) measurements range from 2 to 6 corresponding to a range in the risk of transmission of 100 to 1000 times. Allowing for the fact that those with the highest viral load will infect their partners and die more quickly, 9 removing them from the pool of sero-discordant couples, the rate of transmissions will fall by about 50% after five years as shown in Figure 4 and observed by Wawer et al. 8 (See Appendix 2 for details.) Assuming that their comparison is with the seroprevalent couples one might again reduce the relative risk by a factor of about 2. An inevitable consequence of these estimates is that R 0 must be close to 1 and indeed Hollingsworth et al. 10 give an estimate of 2.2 under random mixing. If this were the case HIV should be much less stable than it is observed to be and small improvements in prevention should have a substantial impact on the epidemic which is not seen to be the case. Again, for the purposes of this analysis, we will use the high estimate from Hollingsworth et al. 10 The estimates of D AP and RR that we will use in this analysis are given in Table 2 . 
The impact of universal testing on transmission
We now wish to explore the consequences for the different estimates of the acute phase duration and the relative infectiousness of the acute phase on the impact of T&T on transmission. The key point is this: one of the few directly observed parameters concerning the epidemiology of HIV is the initial doubling time which, in South Africa, is 1.25 ± 0.25. 11 Since the acute phase lasts for considerably less time than the chronic phase, the greater the relative risk of transmission in the acute phase the smaller must be the value of R 0 to maintain the same initial doubling time. Indeed, if we know the initial doubling time (the growth rate r in Equations 11 and 13 in Appendix 3) and we know the relative risk of infection in the acute phase and each of the four chronic phases (β i /β 0 in Equations 7 to 9 in Appendix 3) and the duration of each of the four stages (1/ρ i in Equations 7 to 9 and 10) in The boundaries of the ellipses indicate the uncertainty in the point estimates which are considerable. Assuming, as noted above, that in the Hollingsworth et al. 10 study the high values of D AP correspond to low values RR, and vice versa, we slant the corresponding confidence ellipse at an appropriate angle. This also serves to show that if we let D AP = 6 mo. The Hollingsworth et al. 10 and the Wawer et al. 8 estimates are not significantly different. 
Conclusion
We have three estimates of RR, the relative risk of infection, and D AP , the duration of the acute phase ranging from 2.1 over 2 months to 26.2 over 3 months giving values of R 0 ranging from 5.8 to 2.3. The high estimates for RR may well be overestimates. They are both based on the data from Rakai 8 and discordant couple studies in which one partner is 'sero-prevalent' will select against those couples who are most infectious and therefore no longer sero-discordant. Furthermore, the high values of RR with long values of D AP imply values of R 0 ≈ 2 which seems unlikely; if this were the case HIV should be relatively easy to eliminate through minor changes in behaviour and the epidemic should be much less stable.
However, it is clear from this analysis that even if we adopt the most pessimistic view and assume the relative risk of infection is 26 times higher during an acute phase that lasts for 3 months annual testing and immediate treatment has the potential to R 0 to less than 1 and with any further contribution to prevention will probably guarantee elimination in the long term. Testing people regularly, on an annual basis, is considerably more effective than random testing because under random testing some people will be tested very frequently, which is not necessary, while others will be tested very infrequently which is not ideal. With regular testing even the most pessimistic view reduces R 0 to 0.82 and will probably lead to elimination. As expected, testing people twice a year reduces R 0 even further and under all assumptions about the acute phase would guarantee elimination.
However, this analysis raises a possibility that may be even more important than considerations of high rates of infection during the acute phase. We know that the set point values of the viral load vary by several orders of magnitude. In the Fiebig 7 study the log 10 (viral load) varies from about 2.6 to 5.6 in the chronic stage.
The data in Figure 4 suggest that variation in the average viral load in a cohort of people, as a function of time since infection, is likely to have a greater influence on the model predictions than any difference between acute and chronic phase transmission. However, there are two reasons why this is more difficult to allow for. First of all the result shown in Figure 4 assumes a relationship between survival and set-point viral load based on only one small study and better data are needed if this is to be made the basis for modelling the epidemic. Secondly, including this variation would probably need a model that includes the distribution of set-point viral loads explicitly and the structure of the models that are currently used does not allow for this. If this were to be explored further, the first priority would be to consider models in which the variation in the set-point viral load is included explicitly and comparisons made with a model in which this variation is set to zero.
We conclude, therefore, that increased transmission during the acute phase is unlikely to change the model predictions significantly for several reasons: 1. The acute phase duration is more likely to be of the order of one or two months or about 1% to 2% of the total disease duration. 2. If transmission during the acute phase is sufficiently high for transmission during this short time to be important, then R 0 must be correspondingly low and the reduction in R 0 needed for elimination is correspondingly less. 3. There is strong evidence that transmission saturates above a viral load of about 4 to 5 logs mitigating the impact of even very high viral loads during the acute phase. 4. A more important limitation of the current model structures, is that variation in the setpoint viral load is not included and this should be explored further.
5. The short duration of the acute phase means that it can only ever make a significant contribution to transmission if the rate of partner changes is much higher than is generally observed to be the case. 
